Oxycodone | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Oxycodone

PRESS RELEASE

Local pharmacist pleads guilty to unlawful distribution of oxycodone

Abril 27, 2020
TAMPA, Fla. - Hong Truong (54, Dunedin) has pleaded guilty to the unlawful distribution of oxycodone outside the scope of professional practice. Truong faces a maximum penalty of 20 years in federal prison. She has agreed to a money judgment in the amount of $766,819 to the United States, representing...
Abril 27, 2020
PRESS RELEASE

Pooler pharmacy, pharmacist to pay up to $2.2 million for dispensing illegitimate prescriptions

Abril 07, 2020
SAVANNAH, GA: A Savannah-area pharmacy and its pharmacist have agreed to settle federal claims that they unlawfully dispensed controlled substances pursuant to prescriptions by a notorious pill-mill doctor. Under the settlement, Greeson Rx, LLC and Joshua Z. Greeson, of Brooklet, Ga., will pay up to $2.22 million in civil penalties...
Abril 07, 2020
PRESS RELEASE

Wisconsin physician agrees to pay penalties to resolve allegations of prescribing opioids illegally and violating False Claims Act

Abril 06, 2020
MILWAUKEE - DEA Assistant Special Agent in Charge Paul E. Maxwell and United States Attorney Matthew D. Krueger announced today that Dr. Mehran Heydarpour of Brookfield, Wisconsin, agreed to pay $175,000 to resolve allegations that he prescribed opioid pain medications in violation of the Controlled Substances Act and that he...
Abril 06, 2020
PRESS RELEASE

Wisconsin Dentist Pleads Guilty to Oxycodone Diversion Charge

Marzo 16, 2020
MADISON, WIS. – Assistant Special Agent in Charge Paul E. Maxwell and Scott C. Blader, United States Attorney for the Western Distri ct of Wisconsin, announced that Christopher Kania, 40, Portage, Wisconsin, pled guilty on Thursday, March 12, in U.S. District Court in Madison to obtaining oxycodone by use of...
Marzo 16, 2020
PRESS RELEASE

Catskill physician receives 54 months in prison for distribution of opioids, health care fraud, aggravated identify theft, and obstruction of justice

Marzo 06, 2020
ALBANY, N.Y. – Myra Mabry, age 50, of Catskill, New York, was sentenced today to 54 months in prison for unlawfully distributing opioids, for impersonating her patients and defrauding insurance companies as part of the opioids distribution scheme, and for attempting to obstruct the investigation into her criminal activities. The...
Marzo 06, 2020
PRESS RELEASE

San Mateo doctor charged with unlawful distribution of opioids and health care fraud

Marzo 03, 2020
SAN FRANCISCO – A federal grand jury indicted Timothy Mulligan for the unlawful distribution of opioids, including fentanyl, outside the scope of professional practice and health care fraud, announced United States Attorney David L. Anderson and Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux. According to the...
Marzo 03, 2020
PRESS RELEASE

Three doctors indicted for conspiring to distribute oxycodone

Febrero 13, 2020
ST. LOUIS – Eleven individuals were indicted today by a federal grand jury for conspiracy to distribute controlled medications, such as oxycodone, without a legitimate medical purpose, obtaining controlled medication by deceit and subterfuge, paying and receiving illegal kickbacks for referrals to lab for urine tests of the patients, and...
Febrero 13, 2020
PRESS RELEASE

Georgia pharmacy, pharmacist accused in civil suit of unlawfully dispensing thousands of opioids and other controlled substances

Febrero 12, 2020
BRUNSWICK, Ga. – A South Georgia pharmacy and its pharmacist are accused in a newly filed federal civil complaint with dispensing thousands of highly addictive controlled substances in violation of the Controlled Substances Act. Chip’s Discount Drugs Inc., Chips Discount Drugs LLC, and pharmacist Rogers Wood, of Hazlehurst, Ga., are...
Febrero 12, 2020
PRESS RELEASE

Pain clinic owner pleads guilty to tax evasion and money laundering

Febrero 04, 2020
TAMPA, Fla. - Tom Wynne pleaded guilty to one count of conspiracy to commit tax evasion, one count of tax evasion, and seven counts of money laundering. He faces a maximum penalty of 5 years in federal prison for each of the tax-related counts and up to 10 years in...
Febrero 04, 2020
PRESS RELEASE

Leader of prescription fraud ring sentenced to over three years in federal prison

Enero 30, 2020
INDIANAPOLIS – DEA Indianapolis District Office Assistant Special Agent in Charge J. Michael Gannon and United States Attorney Josh J. Minkler announced today, Brandon Fuller, 27, of Chicago, was sentenced to 40 months in federal prison, by U.S. District Judge James R. Sweeney II, after having pleaded guilty to charges...
Enero 30, 2020
Showing 191 - 200 of 272 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 19
  • Current page 20
  • Página 21
  • Página 22
  • Siguiente página ›
  • Última página »

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español